Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Alcoholic extract of Eclipta alba may help treat allergies and is safe at high doses.

Apoptosis contributes to hair loss in androgenetic alopecia.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.